iSpecimen Upsizes Offering to $5M, Discloses $2M Marketing Contract with IR Agency

summarizeSummary

iSpecimen upsized its ongoing offering to $5 million and disclosed a $2 million marketing contract with IR Agency LLC, a firm that has already collected $5.5 million from the company. The offering, priced near all-time lows, is highly dilutive but necessary given the company's severe cash crunch.

check_boxKey Events · Financing and Capital Events · ISPC

• Offering Upsized to $5M

  Amendment No. 2 increases the offering from $4 million to $5 million, registering up to 2.09 million shares at an assumed price of $2.39, near the 52-week low of $2.15.

• Highly Dilutive Raise

  If fully sold, the offering would add 2.09 million shares to the current 1.52 million outstanding, representing dilution of over 130% for existing holders.

• $2M Marketing Contract with IR Agency

  A new exhibit reveals a $2 million consulting agreement with IR Agency LLC for marketing services, payable from offering proceeds. IR Agency has already received $5.5 million from iSpecimen for similar services.

• Going Concern and Cash Crunch

  The company has a going concern warning, an 85% revenue drop in Q1 2026, and a market cap of only $3.4 million. The offering is essential to fund operations for an estimated seven months.

auto_awesomeAnalysis · ISPC · Industrial Applications And Services

iSpecimen increased its best-efforts offering from $4 million to $5 million, adding 2.09 million shares at an assumed $2.39 — near the 52-week low of $2.15. The amendment also reveals a $2 million marketing contract with IR Agency LLC, payable from offering proceeds, which has already received $5.5 million from the company for similar services. With a going concern warning, an 85% revenue drop, and a market cap of just $3.4 million, this deeply dilutive raise is critical for survival but comes at a steep cost to existing shareholders.